Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub‐Saharan Africa
Source: Tropical Medicine & International Health, Volume 17, Number 8, 1 August 2012 , pp. e38-e48(11)
Objective To compare socio‐demographic patterns in access to antiretroviral therapy (ART) across four community HIV cohort studies in Africa.
Methods Data on voluntary counselling and testing and ART use among HIV‐infected persons were analysed from Karonga (Malawi), Kisesa (Tanzania), Masaka (Uganda) and Manicaland (Zimbabwe), where free ART provision started between 2004 and 2007. ART coverage was compared across sites by calculating the proportion on ART among those estimated to need treatment, by age, sex and educational attainment. Logistic regression was used to identify socio‐demographic characteristics associated with undergoing eligibility screening at an ART clinic within 2 years of being diagnosed with HIV, for three sites with information on diagnosis and screening dates.
Results Among adults known to be HIV‐infected from serological surveys, the proportion who knew their HIV status was 93% in Karonga, 37% in Kisesa, 46% in Masaka and 25% in Manicaland. Estimated ART coverage was highest in Masaka (68%) and lowest in Kisesa (2%). The proportion of HIV‐diagnosed persons who were screened for ART eligibility within 2 years of diagnosis ranged from 14% in Kisesa to 84% in Masaka, with the probability of screening uptake increasing with age at diagnosis in all sites.
Conclusions Higher HIV testing rates among HIV‐infected persons in the community do not necessarily correspond with higher uptake of ART, nor more equitable treatment coverage among those in need of treatment. In all sites, young adults tend to be disadvantaged in terms of accessing and initiating ART, even after accounting for their less urgent need.
Document Type: Research Article
Affiliations: 1: London School of Hygiene and Tropical Medicine, London, UK 2: Medical Research Council, Entebbe, Uganda 3: Biomedical Research and Training Institute, Harare, Zimbabwe 4: National Institute of Medical Research, Mwanza, Tanzania 5: Imperial College, London, UK
Publication date: 1 August 2012